Skip to content
by Legal Desire
2 September 2022

Herbert Smith Freehills Advises Sponsors On Biocytogen Pharmaceuticals’ Hong Kong Ipo

Advising firms

Deal team

17 lawyers named
LawyerFirmSeniorityPracticeOffice
Matt Emsley Lead Herbert Smith Freehills Partner Not stated Hong Kong
Stanley Xie Lead Herbert Smith Freehills Partner Not stated Not stated
Jin Kong Lead Herbert Smith Freehills Other Not stated Hong Kong
Jaime Fong Herbert Smith Freehills Senior associate Not stated Not stated
Cyrus Wong Herbert Smith Freehills Associate Not stated Not stated
Kristina Li Herbert Smith Freehills Associate Not stated Not stated
Sean Ji Herbert Smith Freehills Associate Not stated Not stated
Haiyun Chen Herbert Smith Freehills Associate Not stated Not stated
Ting Wang Herbert Smith Freehills Associate Not stated Not stated
Han Ye Herbert Smith Freehills Other Not stated Not stated
Ariel Lin Herbert Smith Freehills Other Not stated Not stated
Hilary Chong Herbert Smith Freehills Other Not stated Not stated
Colbert Hung Herbert Smith Freehills Trainee Not stated Not stated
Jessica Lu Herbert Smith Freehills Other Not stated Not stated
Tiffany Chan Herbert Smith Freehills Other Not stated Not stated
Marine Jin Herbert Smith Freehills Other Not stated Not stated
Jean Zhou Herbert Smith Freehills Other Not stated Not stated

Stated terms

Stated value
Not stated
What the figure measures
Not stated
Client
Not stated
Counterparties
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Issuer)
Goldman Sachs (Underwriters)
China International Capital Corporation (Underwriters)